Actuate Therapeutics receives Nasdaq delisting notice for MVLS below $50M

ACTUATE THERAPEUTICS, INC.

Received Nasdaq notice on July 15, 2026 that Market Value of Listed Securities fell below $50M minimum.
Has 180 calendar days, until January 11, 2027, to regain compliance by closing at $50M+ for 10 consecutive days.
If not compliant by deadline, Nasdaq will issue delisting notice; company may appeal or apply to transfer to Nasdaq Capital Market.
Common stock continues trading under symbol ACTU with no immediate effect on listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.